Qube Research & Technologies LTD Xencor Inc Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Xencor Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 135,047 shares of XNCR stock, worth $2.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

135,047

Previous 123,414 9.43%

Holding current value

$2.86 Million

Previous $2.73 Million 6.41%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$18.21 - $24.5 $211,836 - $285,008	11,633 Added 9.43%	135,047 $2.56 Million
Q1 2024 May 14, 2024	SELL	$18.65 - $26.52 $418,356 - $594,896	-22,432 Reduced 15.38%	123,414 $2.73 Million
Q4 2023 Feb 13, 2024	BUY	$16.53 - $21.42 $1.82 Million - $2.36 Million	110,360 Added 311.0%	145,846 $3.1 Million
Q3 2023 Nov 13, 2023	SELL	$20.08 - $25.39 $151,965 - $192,151	-7,568 Reduced 17.58%	35,486 $715,000
Q2 2023 Aug 14, 2023	BUY	$24.77 - $29.9 $1.07 Million - $1.29 Million	43,054 New	43,054 $1.08 Million
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $293,389 - $365,228	11,835 Added 140.13%	20,281 $528,000
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $145,184 - $191,298	-5,897 Reduced 41.11%	8,446 $219,000
Q2 2022 Aug 15, 2022	SELL	$19.74 - $29.01 $1.02 Million - $1.5 Million	-51,621 Reduced 78.26%	14,343 $393,000
Q1 2022 May 09, 2022	BUY	$26.68 - $41.63 $1.76 Million - $2.75 Million	65,964 New	65,964 $1.76 Million
Q3 2021 Nov 12, 2021	SELL	$30.65 - $35.68 $668,384 - $778,073	-21,807 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$34.33 - $44.68 $346,183 - $450,553	10,084 Added 86.02%	21,807 $752,000
Q1 2021 May 14, 2021	BUY	$40.81 - $53.88 $185,971 - $245,531	4,557 Added 63.59%	11,723 $505,000
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $262,490 - $341,316	7,166 New	7,166 $313,000

Others Institutions Holding XNCR

# of Institutions

204

Shares Held

63.1M

Call Options Held

3.9K

Put Options Held

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.27B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Xencor Inc Transaction History